{"nct_id":"NCT00410124","title":"RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib","status":"COMPLETED","status_verified_date":"2012-12","start_date":"2006-11","start_date_type":null,"primary_completion_date":"2008-02","primary_completion_date_type":"ACTUAL","completion_date":"2011-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}